BCRX

#1835
BioCryst Pharmaceuticals Inc
9.67 USD
+2.65%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
9.67
9.67
Intervallo Annuale
6.00
11.31
Variazione giornaliera
+2.65%
Variazione Mensile
+17.64%
Variazione di 6 mesi
+48.31%
Variazione Annuale
+38.34%
Chiusura Precedente
9.42
Apertura
9.67
Bid
Ask
Minimo
9.67
High
9.67
Volume
103
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 2.43 B
  • Employee 435
  • Founded 1986
  • CEO Jon P. Stonehouse
  • Website www.biocryst.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLYWX6
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
6.45
Rapporto prezzo/fatturato
1.95

BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

Notizie